Document 0068
 DOCN  M9650068
 TI    [HCV antibodies in hemodialyzed patients in Tunisia]
 DT    9605
 AU    Hmida S; Mojaat N; Chaouchi E; Mahjoub T; Khlass B; Abid S; Boukef K;
       Centre National de Transfusion Sanguine, TUNIS, Tunisie.
 SO    Pathol Biol (Paris). 1995 Sep;43(7):581-3. Unique Identifier : AIDSLINE
       MED/96146822
 AB    The prevalence of seropositivity to Hepatitis C and B virus and HIV
       infection in Haemodialysis patients was assessed in sera from 235
       patients from 6 dialysis units in Tunisia. Anti-HCV antibodies were
       found in 106 patients (45.10%), the hepatitis B surface antigene was
       found in 19 patients (8%), and no case of HIV infection was found.
       Anti-HCV positivity was correlated with duration of dialysis (p <
       0.001). There was no correlation between anti-HCV positivity and the
       number of transfusions.
 DE    Adult  Aged  Aged, 80 and over  English Abstract  Enzyme-Linked
       Immunosorbent Assay  Female  Hemodialysis/*ADVERSE EFFECTS  Hepatitis
       B/*EPIDEMIOLOGY/ETIOLOGY  Hepatitis B Surface Antigens/ANALYSIS
       Hepatitis C/*EPIDEMIOLOGY/ETIOLOGY/TRANSMISSION  Hepatitis C
       Antibodies/*ANALYSIS  Human  HIV Antibodies/ANALYSIS  HIV
       Infections/*EPIDEMIOLOGY/ETIOLOGY  HIV Seroprevalence  Male  Middle Age
       Prevalence  Tunisia/EPIDEMIOLOGY  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).